ALSPIROS 140 MCG (ALBUTEROL SULFATE INHALATION POWDER) FOR USE WITH SPIROS
Case File Statements
D10000: "140 MCG (ALBUTEROL SULFATE INHALATION POWDER) FOR USE WITH"
GS0051: pharmaceutical preparations for the treatment of diseases of the human respiratory, cardiovascular, endocrine, reproductive, neurologic, immune, gastrointestinal and musculoskeletal systems, for the treatment of hematologic and bone disorders, infectious diseases, and for metabolic and oncologic diseases
Case File Event Statements
3/16/2001 - 23 years ago
12 - ABANDONMENT - NO USE STATEMENT FILEDType:ABN6
3/17/2000 - 24 years ago
11 - EXTENSION 1 GRANTEDType:EX1G
1/12/2000 - 25 years ago
10 - EXTENSION 1 FILEDType:EXT1
7/20/1999 - 25 years ago
9 - NOA MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
4/27/1999 - 25 years ago
8 - PUBLISHED FOR OPPOSITIONType:PUBO
3/26/1999 - 25 years ago
7 - NOTICE OF PUBLICATIONType:NPUB
2/4/1999 - 26 years ago
6 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
12/29/1998 - 26 years ago
5 - EXAMINER'S AMENDMENT MAILEDType:CNEA
11/2/1998 - 26 years ago
4 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA